Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
Le Saux O, Bourmaud A, Rioufol C, Colomban O, Guitton J, Schwiertz V, Regnier V, You B, Ranchon F, Maraval-Gaget R, Girard P, Chauvin F, Freyer G, Tod M, Henin E, Trillet-Lenoir V. Le Saux O, et al. Among authors: chauvin f. Cancer Chemother Pharmacol. 2018 Aug;82(2):319-327. doi: 10.1007/s00280-018-3612-x. Epub 2018 Jun 15. Cancer Chemother Pharmacol. 2018. PMID: 29948022
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
Bourmaud A, Henin E, Tinquaut F, Regnier V, Hamant C, Colomban O, You B, Ranchon F, Guitton J, Girard P, Freyer G, Tod M, Rioufol C, Trillet-Lenoir V, Chauvin F. Bourmaud A, et al. Among authors: chauvin f. BMC Res Notes. 2015 Jul 4;8:291. doi: 10.1186/s13104-015-1231-8. BMC Res Notes. 2015. PMID: 26142140 Free PMC article.
Conditions for the Implementation of a Patient Education Program Dedicated to Cancer Patients Treated by Oral Anticancer Therapy.
Verot E, Falandry C, Régnier Denois V, Feutrier C, Chapoton B, Okala J, Pupier S, Rousset V, Bridet F, Ravot C, Rioufol C, Trillet-Lenoir V, Hureau M, Chauvin F, Bourmaud A. Verot E, et al. Among authors: chauvin f. Patient Prefer Adherence. 2020 Nov 19;14:2263-2277. doi: 10.2147/PPA.S268953. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 33244223 Free PMC article.
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT).
Trillet-Lenoir V, Mornex F, Chauvin F, Fournel P, Voloch A, Perol M, Laennec E, Piperno D, Boyer J, Ardiet JM, et al. Trillet-Lenoir V, et al. Among authors: chauvin f. Lung Cancer. 1993 Oct;10(1-2):35-45. doi: 10.1016/0169-5002(93)90307-j. Lung Cancer. 1993. PMID: 8069602 Clinical Trial.
Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study.
Bourmaud A, Anota A, Moncharmont C, Tinquaut F, Oriol M, Trillet-Lenoir V, Bajard A, Parnalland S, Rotonda C, Bonnetain F, Pérol D, Chauvin F. Bourmaud A, et al. Among authors: chauvin f. Br J Cancer. 2017 Mar 28;116(7):849-858. doi: 10.1038/bjc.2017.31. Epub 2017 Feb 14. Br J Cancer. 2017. PMID: 28196066 Free PMC article. Clinical Trial.
229 results